Literature DB >> 35370518

Are Physical Fitness and CRP Related to Framingham Risk Score in HIV+ Adults?

John E Lewis1,2,3,4,5,6, Jillian Poles1,2,3,4,5,6, Eleanor Garretson1,2,3,4,5,6, Eduard Tiozzo1,2,3,4,5,6, Sharon Goldberg1,2,3,4,5,6, Carmen S G Campbell1,2,3,4,5,6, Herbert G Simões1,2,3,4,5,6, Judi M Woolger1,2,3,4,5,6, Janet Konefal1,2,3,4,5,6.   

Abstract

Background. People living with HIV (PLWH) have increased risk of cardiovascular disease (CVD). The Framingham Risk Score (FRS) predicts a 10-year CVD risk. Its relationships to physical fitness and C-reactive protein (CRP) are not well established. The current aim is to determine the links between FRS, physical fitness, and CRP in PLWH. Methods. Participants (n = 87) were assessed on multiple biomarkers. The FRS was calculated with the respective variables. Other variables that correlated significantly with FRS were entered into a regression equation to determine their relationship to FRS. Results. The FRS for men was more than twice that for women (12.8 vs 6.0, P < .001). Men were more fit than women, but most participants were not fit. Aerobic capacity was predictive of FRS in men, but not in women, and muscular strength was not predictive of FRS. Women had more than double the CRP compared with men (7.9 vs 3.5 mg/L, P < .01), and it was unrelated to FRS. Conclusions. In men, aerobic capacity was significantly predictive of FRS, but muscular strength and CRP were unrelated to FRS in both genders. These results do not conclusively demonstrate that physical fitness and CRP are related to FRS in PLWH.
© 2020 The Author(s).

Entities:  

Keywords:  C-reactive protein; Framingham Risk Score; aerobic capacity; muscular strength; people living with HIV

Year:  2020        PMID: 35370518      PMCID: PMC8971702          DOI: 10.1177/1559827620904345

Source DB:  PubMed          Journal:  Am J Lifestyle Med        ISSN: 1559-8276


  58 in total

1.  Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects.

Authors:  B M Bergersen; L Sandvik; J N Bruun; S Tonstad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-28       Impact factor: 3.267

2.  Cardiovascular risk assessment using pulse pressure in the first national health and nutrition examination survey (NHANES I).

Authors:  M Domanski; J Norman; M Wolz; G Mitchell; M Pfeffer
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

Review 3.  Cardiorespiratory fitness levels and moderators in people with HIV: A systematic review and meta-analysis.

Authors:  Davy Vancampfort; James Mugisha; Simon Rosenbaum; Joseph Firth; Marc De Hert; Michel Probst; Brendon Stubbs
Journal:  Prev Med       Date:  2016-10-03       Impact factor: 4.018

4.  Higher pulse pressure and risk for cardiovascular events in patients with essential hypertension: The Campania Salute Network.

Authors:  Costantino Mancusi; Maria A Losi; Raffaele Izzo; Grazia Canciello; Maria V Carlino; Giovanni Albano; Nicola De Luca; Bruno Trimarco; Giovanni de Simone
Journal:  Eur J Prev Cardiol       Date:  2017-12-11       Impact factor: 7.804

5.  C-reactive protein as a predictor of cardiovascular risk in HIV-infected individuals.

Authors:  Clare L V Westhorpe; Hans G Schneider; Mandy Dunne; Tracey Middleton; Vijaya Sundararajan; Tim Spelman; Vanessa Carter; Suzanne M Crowe; Anthony Dart; Anne Mijch; Despina Kotsanas; Ian Woolley
Journal:  Sex Health       Date:  2014-12       Impact factor: 2.706

Review 6.  Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis.

Authors:  F M Islam; J Wu; J Jansson; D P Wilson
Journal:  HIV Med       Date:  2012-03-14       Impact factor: 3.180

7.  HIV infection and the risk of acute myocardial infarction.

Authors:  Matthew S Freiberg; Chung-Chou H Chang; Lewis H Kuller; Melissa Skanderson; Elliott Lowy; Kevin L Kraemer; Adeel A Butt; Matthew Bidwell Goetz; David Leaf; Kris Ann Oursler; David Rimland; Maria Rodriguez Barradas; Sheldon Brown; Cynthia Gibert; Kathy McGinnis; Kristina Crothers; Jason Sico; Heidi Crane; Alberta Warner; Stephen Gottlieb; John Gottdiener; Russell P Tracy; Matthew Budoff; Courtney Watson; Kaku A Armah; Donna Doebler; Kendall Bryant; Amy C Justice
Journal:  JAMA Intern Med       Date:  2013-04-22       Impact factor: 21.873

8.  Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection.

Authors:  C J Fichtenbaum; D B Clifford; W G Powderly
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-10-01

9.  Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?

Authors:  E Fontas; F van Leth; C A Sabin; N Friis-Møller; M Rickenbach; A d'Arminio Monforte; O Kirk; M Dupon; L Morfeldt; S Mateu; K Petoumenos; W El-Sadr; S de Wit; J D Lundgren; C Pradier; P Reiss
Journal:  J Infect Dis       Date:  2004-03-02       Impact factor: 5.226

10.  The Effect of a Community-Based Exercise Program on Inflammation, Metabolic Risk, and Fitness Levels Among Persons Living with HIV/AIDS.

Authors:  Stacy E Cutrono; John E Lewis; Arlette Perry; Joseph Signorile; Eduard Tiozzo; Kevin A Jacobs
Journal:  AIDS Behav       Date:  2016-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.